Sucampo Pharmaceuticals (SCMP) Earns News Impact Rating of 0.24
Sucampo Pharmaceuticals, Inc. | May 17, 2017
News articles about Sucampo Pharmaceuticals (NASDAQ:SCMP) have trended somewhat positive on Wednesday, AlphaOne reports. The research firm, a service of Accern.